Please login to the form below

Not currently logged in
Email:
Password:

Ferring

This page shows the latest Ferring news and features for those working in and with pharma, biotech and healthcare.

Finch’s microbiota drug for C. diff gets FDA breakthrough status

Finch’s microbiota drug for C. diff gets FDA breakthrough status

tries to bring the drug to market ahead of rival microbiota products from Ferring/Rebiotix and Takeda/NuBiyota. ... The Minnesota-based biotech, which was acquired by Swiss drugmaker Ferring last year, has been awarded a BTD for its therapy and is also

Latest news

  • Big Pharma, Little Pharma Big Pharma, Little Pharma

    to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and Ferring with women’s health.

  • Ferring agrees Chinese reproductive medicine research deal Ferring agrees Chinese reproductive medicine research deal

    Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) are set to collaborate on a long-term project to advance basic and translational research in reproductive medicine. ... Per Falk, executive vice president and chief scientific officer of

  • SMC gives green light for Amgen’s Kyprolis SMC gives green light for Amgen’s Kyprolis

    Ferring Pharmaceutical’s idiopathic nocturnal polyuria drug Noqdirna (desmopressin oral lypohilisate) also received a green light, however Biofrontera’s Ameluz (aminolaevulinic acid hydrochloride) wasn’t as lucky as the committee said

  • Merck's pharma unit faces tougher 2017 as fertility boost recedes Merck's pharma unit faces tougher 2017 as fertility boost recedes

    company. Throughout 2016 Merck's Gonal-f fertility drug has benefited from reduced competition from Ferring's Bravelle range, which was pulled from the US market last year because of quality

  • Fertility drugs drive healthcare growth at Merck KGaA Fertility drugs drive healthcare growth at Merck KGaA

    The company put the performance in the quarter down to the withdrawal of a rival product - Ferring's Bravelle - from the US market last year because of quality issues, as well

More from news
Approximately 6 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    138.5. TxCell/ Ferring. Collaboration, option,  licence. Ovasave - personalised cell-based immunotherapy for IBD (inc Crohn's disease, ulcerative colitis) (p2).

  • Interview: Michel Pettigrew, Ferring Interview: Michel Pettigrew, Ferring

    Single-minded pursuit of progress. So, how does Ferring stand out within the industry? ... As Pettigrew notes, in Ferring's case 'privately owned' really does mean 'privately owned'.

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    Ferring Pharmaceuticals has bolstered its oncology division team, appointing Sophie Opdyke (pictured below) as its vice president, general manager. ... leadership team.”. Opdyke, who has more than 20 years’ experience, joins Ferring from Pfizer,

  • IFPMA names new communications director IFPMA names new communications director

    Helen Gallagher joins the association from Ferring Pharmaceuticals. IFPMA has appointed Helen Gallagher as  its new communications director, a role that will see her act as a key spokesperson for the ... Prior to her new role at IFPMA, Gallagher headed

  • Sobi appoints Torbjorn Hallberg as general counsel Sobi appoints Torbjorn Hallberg as general counsel

    He arrives at Sobi will more than 15 years’ experience covering licensing, mergers and acquisitions at pharma groups such as  Ferring and Nycomed.

  • Ferring appoints executive VP and chief medical officer Ferring appoints executive VP and chief medical officer

    Professor Klaus Dugi joins the pharma group from Boehringer Ingelheim. Ferring Pharmaceuticals has appointed professor Klaus Dugi as its executive vice president and chief medical officer; roles that will see him ... Michel Pettigrew, president of the

  • Ferring promotes Lars Peter Brunse to chief production officer Ferring promotes Lars Peter Brunse to chief production officer

    He also joins the Swiss pharma firm's executive board. Saint-Prex, Switzerland-based Ferring Pharmaceuticals has appointed Lars Peter Brunse as its vice president and chief production officer, roles that ... Prior to joining Ferring, Brunse served Novo

More from appointments
Approximately 7 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics